Select Language
Free Registration

DNA polymerase I

DNA polymerase I Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Bacillus stearothermophilus (1)

  • Tag

    - (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
DNI-B5113
Bacillus stearothermophilus
E. coli
Bst DNA Polymerase
Total: 1
  • 1

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Clofarabine (Boyen)BY-101Phase 3 ClinicalBoyen Therapeutics IncLeukemia, Myeloid, Acute
Details
Alkasar-18NOAC; Alkasar-18; N4-octadecyl-ara-CPhase 2 ClinicalUniversity of ZurichCerebral Hemorrhage; Neoplasms; Atrial Fibrillation
Details
SapacitabineCS-682; CYC-682Phase 2 ClinicalDaiichi Sankyo Co LtdLeukemia; Myelodysplastic Syndromes; Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Carcinoma, Non-Small-Cell Lung
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
ClofarabineCAFdA; JC0707; GZ-393590; SAR-393590; 2-Cl-2-F-araAApprovedGenzyme CorpClolar, Evoltra, Ivozall, ClofarexUnited StatesPrecursor Cell Lymphoblastic Leukemia-LymphomaGenzyme Corp2004-12-28Lymphoma, Large B-Cell, Diffuse; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Lymphoproliferative Disorders; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Histiocytosis, Langerhans-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Multiple Myeloma; Hematologic Neoplasms; Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Lymphoid; Lymphoma, B-Cell, Marginal Zone; Lymphoma, B-Cell; Lymphoma, T-Cell, Peripheral; Intestinal Neoplasms; Solid tumours; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid; Leukemia
Details
Nelarabine506U; 506-U78; GW-506U; GW-506U78; GI-262250X; NSC-686673ApprovedNovartis Pharma Ag, Glaxosmithkline PlcArranon, ArranonG, AtrianceUnited StatesPrecursor T-Cell Lymphoblastic Leukemia-LymphomaSandoz2005-10-28Sezary Syndrome; Mycosis Fungoides; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia; Lymphoma; Lymphoma, T-Cell; Leukemia; Lymphoma, Follicular; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Multiple Myeloma; Myeloproliferative Disorders; Myelodysplastic Syndromes; Plasmacytoma; Lymphoma, B-Cell, Marginal Zone
Details
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland